Nate joined Oxford Science Enterprises in September 2023, bringing significant experience across commercial and innovation roles.
At OSE, Nate will focus on identifying new investment opportunities, with the goal of creating and building a new Health Tech company. Nate will additionally advise current portfolio companies on business modelling and commercial strategy.
Nate joins OSE from Kenvue (formerly Johnson & Johnson Consumer Health), where he spent close to 20 years working in various commercial leadership roles, most recently leading digital capability acceleration for the $7b North America business. Previously, he led global marketing and innovation teams for multiple categories across J&J’s $6b Global OTC business.
Nate holds an MBA from The DeGroote School of Business at McMaster University and a BComm in Marketing from The University of Guelph.
